Skip to content

A Comparative study between oral Labetalol and oral Nifedipine in gestational hypertension

A comparative study between oral Labetalol and oral Nifedipine in pregnancy induced hypertension - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082731
Enrollment
80
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O134- Gestational [pregnancy-induced] hypertension without significant proteinuria, complicating childbirth

Interventions

Intervention1: Tab Nifedipine: Tab Nifedipine 10mg Intervention2: Tab Labetalol: Tab labetalol 100mg OD for 3 days Control Intervention1: Oral Nifedipine: tab Nifedipine 10mg OD for 3 days

Sponsors

Swagata Dey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women more than 20 weeks of gestation with blood pressure reading =140/90 mmHg and medical decision to control blood pressure rapidly were included for the study.

Exclusion criteria

Exclusion criteria: 1. Patients who do not consent for participation in the study 2. Patients with chronic hypertension i.e. known cases of hypertension or hypertension diagnosed first time in pregnancy but before 20 weeks of gestational age. 3. Women with a history of heart rhythm abnormality, heart failure, asthma, allergy to either of the drugs, non-pregnancy related hypertension are to be excluded from the study. 4. Patients receiving any other antihypertensive drug preceding 72 hours of admission will also be excluded from study. 5. History of Smoking 6. Any chronic medical illness with pre existing renal disease, liver disease 7. Patients who are not willing to give consent

Design outcomes

Primary

MeasureTime frame
Time (minutes) taken to achieve blood pressure =140/90 mmHg Total antihypertensive doses to achieve blood pressure =140/90 mmHgTimepoint: 8 weeks

Secondary

MeasureTime frame
Mode of delivery Baby weight Neonatal complications Maternal complications Apgar score at 5 min Neonatal statusTimepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Purashree Sarma

Tezpur Medical College and Hospital

purashreesarma@gmail.com9101588288

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026